Better Plant Ready for U.S. Sales of its FDA Listed Gel-Based Hand Sanitizer

Vancouver, B.C. – September 10, 2020: Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FE: YG3) (“Better Plant”) or (the “Company”) is pleased to announce that subsidiary Urban Juve has completed manufacturing of its hand sanitizer gel and is launching the product in both Canada and the U.S. The hand sanitizer gel is listed with the FDA (NDC 75385-0010-1) and has received Natural health Product Number 80098154 from Health Canada. Urban Juve’s Ultra Hydrating Hand Sanitizer Spray received Health Canada approval on March 27, 2020 (NPN 80097926) and is for sale on and Canadian retail stores including select Pharmasave stores. The newly listed hand sanitizer gel is now for sale on in both Canada and the US, with free shipping on orders of $50 or more.

“The gel is formulated with 65% ethyl alcohol which helps kill germs, while aloe vera and eucalyptus essential oil protect the skin.” says Amber Allen, VP of Sales for Better Plant. “We believe there is an opportunity in the marketplace for high quality hand sanitizers at a reasonable price, with essential oils that provide health benefits. It is exciting that we are now FDA listed and can start shipping this fantastic product to the USA.”

According to, the market for hand sanitizer across the globe is expected to rise over 600% during 2020, fueled by preventative recommendations by the World Health Organization and driven by the ability of alcohol-based sanitizers to prevent infections and kill bacteria, fungi, and viruses.

One of the most common complaints with hand sanitizers are that the alcohol can cause the skin to dry out and sometimes even crack. “In order to create a truly moisturizing, nourishing and luxurious product, we have blended aloe vera extract for skin hydration, witch hazel for its anti-inflammatory and antiviral properties, and essential oils to protect the skin,” says Bhavna Solecki Director of Research and Product Development. “One of the unique selling points of our hand sanitizer is that it is formulated specifically to hydrate the skin and protect it from harmful germs.” 

The hand sanitizer market is expected to grow at a CAGR of over 17 per cent between 2019 and 2025 according to a report from Aritzon, with sales expected to reach USD $11-billion in 2020, a 600-per-cent increase over last year.


About Better Plant Sciences Inc. 

Better Plant develops and acquires intellectual property and other assets related to plant-based products and therapeutics. Through its integrated business model, Better Plant develops, manufactures, markets, sells and distributes plant-based products. It has 14 patent applications to protect its Intellectual Property, and over 200 proprietary wellness formulas at various stages of commercialization, including over 20 proprietary products that are now for sale via eCommerce or brick-and-mortar retail stores. It operates websites and oversees eCommerce and Amazon sales for over 200 JUSU plant based products for body, baby and home. Its majority-owned subsidiary NeonMind Biosciences Inc. is launching a line of coffees infused with health optimizing medicinal mushrooms including reishi, cordyceps, lion’s mane and turkey tail mushrooms. NeonMind is also engaged in research into developing a psilocybin (psychedelic mushroom) based product for weight loss and has applied for a Section 56 Exemption to begin preclinical trials to study its pending psychedelic medicine patents.


For more information about Better Plant, visit or follow @betterplantsciences on Instagram.


Investor Relations Contact:

Penny White, President & CEO

Kevan Matheson, Investor Relations 


The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.


Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation.  Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements.  Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, brand development, availability of packaging, intellectual property protection, reduced global commerce and reduced access to raw materials and other supplies due to the spread of the Coronavirus, the potential for not acquiring any rights as a result of the patent  application and any products making use of the intellectual property may be ineffective or the company may be unsuccessful in commercializing them; and other approvals will be required before commercial exploitation of the intellectual property can happen.  Demand for the company’s products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets.  Better cautions readers not to place undue reliance on forward-looking statements provided by Better, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Better expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.


Leave a Reply